Measurement of Salivary Resistin Level in Patients with Type 2 Diabetes
Table 1
The general information and laboratory data of the new diagnosed type 2 diabetic patients and non-diabetes mellitus.
Control
T2DM
Participants (M/F)
35 (18/17)
38 (18/20)
Age (years)
43 ± 13
45 ± 10
Body mass index (kg/m2)
23.9 ± 3.3
25.5 ± 4.9
Waist circumference (cm)
83.1 ± 6.0
92.2 ± 5.1
Systolic pressure (mmHg)
125.1 ± 12.4
138.0 ± 18.3
Diastolic pressure (mmHg)
78.3 ± 8.2
86.1 ± 9.3
Fasting plasma glucose (mM)
6.1 ± 0.9
7.4 ± 1.7*
HbA1c (%)
6.0 ± 0.6
7.1 ± 0.6*
Fasting insulin (mIU/L)
5.7 ± 2.8
9.2 ± 6.2*
HOMA-IR
3.3 (2.5~4.6)
5.5 (3.6~6.7)*
Fasting serum resistin (ng/mL)
6.1 ± 0.6
12.3 ± 2.7*
Fasting saliva resistin (ng/mL)
1.5 ± 0.3#
3.4 ± 0.4*#
Fasting saliva flow rate (mL/min)
2.2 ± 0.8
2.4 ± 1.1
Results are displayed as mean values ± standard deviation. Data of nonnormal distribution were described using the median (M) and quartile (Q1~Q4). : comparison of resistin level between T2DM group and non-diabetes mellitus group. : comparison between serum resistin level and saliva resistin level.
